Status | Awaiting development |
Process | QS |
ID number | 0 |
Email enquiries
- If you have any queries please email qualitystandards@nice.org.uk
Timeline
Key events during the development of the guidance:
Date | Update |
---|---|
30 June 2021 | Awaiting development. After reviewing current priorities this topic has been stopped. |
20 April 2021 | In progress. Development of this quality standard has restarted and the timelines have been updated. |
24 June 2020 | In progress. We are currently undertaking a phased restart of quality standards development. This topic has not been identified as a priority for the initial phase of restarting development but will be rescheduled into the work programme in due course. |
06 April 2020 | Topic update: this quality standard has not been defined as therapeutically critical (please follow the link titled rapid guidelines and evidence summaries within the yellow banner on the NICE website homepage about for information on recent changes to the way we work). The quality standard will therefore be paused. At this stage, we are unable to provide alternative timelines as to when the quality standard may be re-started but we will provide updates as and when this information becomes clear. |
25 March 2020 | Schedule affected by COVID-19. COVID-19 |
20 January 2020 | In progress. In progress |
24 July 2018 | This QS has been referred to NICE but has not yet been scheduled into the work programme. Topics are prioritised for development annually. https://www.nice.org.uk/standards-and-indicators/selecting-and-prioritising-quality-standard-topics |
For further information on our processes and methods, please see our quality standards process guide.